Oppenheimer Initiates Coverage On Passage Bio with Outperform Rating, Announces Price Target of $30

Oppenheimer analyst Jay Olson has initiated coverage on Passage Bio (NASDAQ: PASG) with an Outperform rating. The firm has set a price target of $30 for the company's stock.